Patient
SITE008-0201
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2026-05-01
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 1 Vomiting — outcome: UNKNOWN; onset 2023-02-07 (study day 94); relationship: not assessed
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-01-22 (study day 78); relationship: NOT RELATED
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-01-07 (study day 63); relationship: NOT RELATED
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-24 (study day 49); relationship: not assessed
Grade 1 Decreased appetite — outcome: UNKNOWN; onset 2022-11-22 (study day 17); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.